MedTrace Logo

Collection of the Thrombo-VaxCov Cohort

NCT04889326 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-05-22

No results posted yet for this study

Summary

In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation.

This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.

Conditions

  • Covid19
  • SARS-CoV Infection
  • Venous Thrombosis
  • Thrombocytopenia
  • Vaccination; Complications

Interventions

OTHER

Retrospective data and biological samples

Analysis of data and biological samples collected during hospitalization:

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Charlotte Cordonnier, MD,PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-02
Primary Completion
2023-05-01
Completion
2023-05-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04889326 on ClinicalTrials.gov